Blog Archives - Page 45 of 81 - NFCR

Blog

Brian Leyland-Jones: Now Is the Time!

“This is the transformative time in oncology,” heralds Brian Leyland-Jones, M.B., B.S., Ph.D., and there is no spin doctoring in the statement by the member of the National Foundation for Cancer Research’s scientific advisory board. From genomics to targeted therapies to vaccinations, the last 40 years has seen more strides…...

Read more

A Major Milestone! Global Coalition Launches World’s First Adaptive Clinical Trial Platform for Glioblastoma

Glioblastoma Multiforme (GBM) is the deadliest and most aggressive form of brain cancer for which there is currently no cure. This often-fatal brain cancer accounts for 45% of all malignant brain tumors and 12,000 cancer diagnoses per year in the United States, in addition to tens of thousands more around…...

Read more

Talented Teens: How Tina Zhang and her teammates use art to change the world

As the long days of summer begin cooling down, it won’t be long until high school halls are filled with eager minds ready to begin a new school year. Many seniors returning for their final year have a lot on their plate. Whether they’re determined to graduate at the top…...

Read more

Dr. Webster Cavenee: Oddball Ideas

When Dr. Webster “Web” Cavenee first introduced the idea of genetic tumor suppressors in 1982, it took to the air like a lead balloon. “I got a lot of blank looks,” he recalls. “A lot of angry ones, too.” How times change. Tumor suppressor genes, also called antioncogenes, are now…...

Read more

Breakthrough: Dr. César Milstein And The MAbs

They are called “mAbs,” short for monoclonal antibodies, and they are a big deal in oncology. One of the immune systems most elegant soldiers, mAbs are formed by B cells, a type of white blood cell produced in the spleen, in response to specific foreign invaders (real and perceived) known…...

Read more